Abstract-The effects of endothelin-1 (ET-1) administered i.v. or intracerebroventricularly (i.c.v.) on arterial pressure (MAP), heart rate and cardiac output were studied in the conscious rat. Systemic injection of ET-1 (0.1 to 1 nmol/kg i.v.) increased dose-dependently MAP and decreased heart rate. The doses of 0.3 and 1 nmoVkg produced initially transient hypotension and tachycardia which were accompanied by a decrease in total peripheral resistance index (TPRI). Cardiac outputwas significantly reduced and TPRI increased during the presser response to 0.3 and 1 nmol/kg ET-1. ET-1 i.c.v. (30pmol/kg) produced a profound presser and vasoconstrictor response which was followed by cardiovascular collapse and death within 20 min after i.c.v. injection. Low doses (1 to 10pmollkg) of ET-1 i.c.v. had no effect on the cardiovascular system.
Introduction
Endothelin is an endothelium-derived 21-residue peptide which has powerful vasoconstrictor potency on a variety of isolated blood vessels and upon intravenous administration in intact animals produces dose-dependent pressor and vasoconDate received 25 May 1989 Date accepted 30 May 1989 strictor effects which are preceded by a transient hypotensive and vasodilator response (1, 2, 3, 4, 5) . In the rat the initial hypotensive response to endothelin was accompanied by carotid and hindquarter skeletal muscle vasodilation and renosplanchnic vasoconstriction which were followed by increases in blood pressure due to strong generalized constriction of all vascular beds ( 5) . However, these experiments were conducted in 231 232 the anesthetized paralyzed rat, a preparation which might not reveal the full scope of hemodynamic responses to endothelin in the conscious state. In the conscious rat, i.v. administration of endothelin was recently reported to produce predominantly vasoconstrictor responses in mesenteric and hindquarter blood vessels {6).
The human endothelin was shown to exist in three isoforms; ET-1 identical to the classical endothelin isolated originally from porcine and human aorta, endothelin-2 identical to the peptide originally derived from human endothelial cells and endothelin-3 identical to endothelin isolated first from rat endothelial cells (2) . The three isoforms of endothelin exhibited distinct profile of cardiovascular activity in anesthetized rats; ET -1 being most potent vasoconstrictor both in vivo and in vitro while endothelin-3 displayed most profaund initial hypotensive response (2) . Tissue autoradiographic sturlies in rats have demonstrated that specific high-affinity binding sites for ET -1 are distributed not only in vascular and cardiac muscle but are abundantly present in the central nervous system (7, 8, 9) . Therefore, the present study was set to examine the effects of endothelin on systemic hemodynamic variables as weil as on blood pressure and cardiac functions in conscious rats after intravenous and intracer· ebroventricular (i.c. v.) administration.
Materials and Methods
Male Sprague-Dawley rats (300-360 g) were purchased from Taconic Farms (Germantown, N.Y.) and housed at 22°C with a 12h/12h Iight/dark cycle. After surgical operations the rats were housed individually in plastic cages (21 x 27 x 16cm, W x L x H) with food and water ad libitum.
Measurement of cardiac output
The cardiac output was measured by thermodilution technique as previously described in detail (10, 11) . The principle of this technique is to produce a change in heat content of blood at one point of the circulation (right atrium) and detect the resultant change in temperature at a point downstream ( ascending aorta). Although the cardiac output values obtained by thermodilution NEUROPEPTIDES tend to be somewhat higher than those determined by electromagnetic ftowmetry (12, 13) or by radioactive microsphere method (14) , the thermodilution method offers many advantages, including (a) the possibility to do repeated cardiac outpul recordings in a conscious chronically instrumented rat and, (b) in contrast to Doppler velocimetry (15) Each rat to undergo cardiac output measurements was anesthetized with an intramuscular injection of ketamine (130mglkg) and acepromazine (1.3mglkg) and a PE-50 catheter was inserted into the left femoral artery. The catheters were tunneled under the skin and exited at the nape of the neck. An incision was made at the midline of the neck from the cricoid to the clavicle, and a PE-50 catheter was inserted into the right atrium via the external jugular vein. The left common carotid artery was exposed and ligated, and a thermistor (MX2-780-33 model THMP f 1.5, Teflon reusable, Columbus Instruments, OH) was advanced through the carotid into the ascending aorta. Placement above the aortic valve was confirmed in each animal by the shape of the dilution curve before the probe was finally sutured to the neck muscles and again at the end of experiment. The jugular vein catheter and the thermistor Ieads were tunneled under the skin to the nape of the neck. All catheters and the probe wire were secured by a soft spring wire attached to the animals's neck using an adhesive collar. Twentyfour hours after the surgery, the arterial line was connected to a pressure transducer (Narco BioSystems model RP 1500i] attached to a strain gauge coupler (Narco Bio-Systems type 7032). Blood pressure (mean, systolic, diastolic, pulse) and heart rate were continuously recorded on a Narcotrace 80 computerized physiograph and sampled automatically at 30-60 s intervals by a Northstar-Hazeltine computer.
To obtain n1easurements of cardiac output, the aortic thermistor was attached to the computerized Cardiomax II (CMX-780-k with microprobe option R, Columbus Instruments, OH). The dead space of the venous line was first flushed with 50 JJ.l of 0.9o/o (wt/vol) NaCl (saline) at room tem-HEMODYNAMIC EFFECTS OF ENDOTHELIN perature (22 °C); after a brief stabilization period an additional injection of 200 ~1 normal saline (22 oc) was rapidly injected into the right atrium using a 1 ml syringe, and the blood temperature monitared by the aortic therrnistor. The thermodilution curve representing the change in aortic temperature was then calculated by the Cardiomax II. A control period of 15 min included two or three cardiac output recordings to test for consistency and placement of the probe. During this time period, control values for blood pressure and heart rate also were collected. The timer for automatic data collection was started and data points for blood pressure, heart rate and cardiac output were collected immediately before and 1, 2.5, 5, 20, 30 and 60 min after drug injections. Total peripheral resistance (TPR) was calculated by dividing the mean arterial pressure by the cardiac output; values of cardiac output and TPR were further indexed per unit ofweight (kg). Core temperature was monitored by the aortic thermoprobe before each cardiac output measurement.
Intracerebroventricular injections
Rats were anesthetized with ketamine-acepromazine ( see above) and placed on a stereotaxic device (David Kopf Instruments, Calif. ). A stainless steel guide cannula was inserted through the skull and fixed with glue (Eastman 910 Adhesive). Coordinates for the injections into the right lateral brain ventricle (i.c. v.) were measured from the bregma: AP = -O.Smm and L = 1.2mm. On the day of the experiment, injections of saline or endothelin were made using a premeasured 30-g (7 .5 mm) cannula inserted into the ventricular space through the guide cannula. The injection cannula was then connected via polyethylene tubing to a Hatnilton microliter syringe, and a volume of 10 ~I of the control or drug solution was injected over a period of 30 seconds. The proper position of the i.c. v. cannula was determined at the end of each experiment by an injection of dye (methylene blue) into the cerebral ventricles.
Statistical analysis of the data
Data in text and figures are means ± S.E. for the given number of rats. Analysis of variance with repeated measures (general MANOVA) and 233 ANOVA with Student-Newman-Keul's test (CSS Complete Statistical System, StatSoft, 1987) were used for statistical analysis of the data.
Drugs used
Endothelin-1 (ET -1, porcine endothelin) was purchased from Peptides International. The stock solution was dissolved in physiological saline (0.9°/o) and stored aliquoted in -20°C. The dil· utions were prepared fresh each day.
Results

A. Hemodynamic effects of intravenously administered endothelin
The effects of increasing doses of ET -1 i. v. on hemodynamic variables are summarized in Figure  1 . Intravenous injection of ET-1 at the doses of 0.1-1 nmol/kg increased dose-dependently mean arterial pressure. The two highest doses (0.3 and 1 nmol/kg) initially decreased blood pressure. The pressor responses to ET -1 were accompanied by bradycardia and the initial depressor phase by a tachycardic response. The maximum increase in blood pressure became apparent 2-5 min after the in jection of the lower doses of ET -1 and these responses subsided within 20 min. After the highest dose the maximum pressor effect was reached in 10 min and the blood pressure remained significantly elevated over the whole observation period of 60 min.
Cardiac index was significantly decreased after 0.3 and 1 nmol/kg doses of ET-1. The decrease in cardiac index after the 1 nmoVkg dose reached its maximum 5 min after ET -1 injection and the cardiac index remained reduced over 60 min. The doses of 0.3 and lnmol/kg of ET-1 initially · decreased total peripheral resistance. The decrease in total peripheral resistance was followed by a sustained vasoconstriction and increase in peripheral resistance.
B. Hemodynamic effects of centrally administered endothelin
The hemodynamic responses to i.c.v. administration of ET-1 at doses of 1, 3, 10 and 30pmol/kg are summarized in 10pmollkg bad no effect on cardiovascular variables, whereas the 30pmollkg produced a profaund pressor response and increase in total peripheral resistance. The mean arterial pressure increased from 123 ± 3 mmHg baseline to 200 ± SmmHg within 5 min after the i.c.v. injection.
Heart rate increased ( + 149 ± 34bpm, p < 0.01 vs.
saline) 15 min after injection. The pressor and tachycardic responses were followed by cardiovascular coJJapse and death (in 7 out of 8 animals) 20 min after the i.c.v. injection of ET-1. The cardiovascular response to the 30pmoUkg dose of ET-1 i.c.v. was accompanied by barrel rolling behaviour within seconds after the i.c. v. injection and at the terminal phase grand mal-type convulsions.
Discussion
Our results are in accordance with recent reports demonstrating pressor responses to intravenous endothelin in the rat (1, 2, 3, 4, 5) . The present study provides a clear mechanism for the increase in systemic blood pressure; peripheral vasoconstriction and elevated TPR. In fact the relatively moderate response to ET -1 could be the result of the counteracting effect of decreased cardiac output by ET -1. Our results are supported by studies showing construction of vascular smooth muscle by endothelin in various in vitro preparations ( 1, 16, 17) and increase regional vascular resistance in vivo in the renal>mesenteric>hindquarter blood vessels after systemic administration of endothelin in intact rats (6, 18) . Several factors could have contributed to the decreased in cardiac index: Heart rate was reduced concomitantly with the decreased cardiac index and a reftex bradycardia due to the increase in systemic pressure could thus confer to the fall in cardiac output. An increased afterload due to elevated peripheral resistance as well as decreased preload due to peripheral vasoconstruction could also contribute to the reduced cardiac output. A direct negative inotropic effect seems unlikely since endothelin was recently shown to increase tension in the isolated rat atrial and papillary muscle (19) . However, reduction in myocardial contractility could be secondary to coronary vasoconstriction (20) .
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At the high doses of ET -1 i. v. the pressor and cardiac depressant effects were preceded by hypotensive and vasodilator responses. An initial hypotensive response preceding the pressor phase of endothelins has been reported after systemic administration of endothelin in a variety of species including the rat (1, 2, 3, 4, 5, 6 ). In the anesthetized cat the depressor response was associated with tachycardia, an increase in cardiac output and reduction of total peripheral resistance (3). In our study the cardiac output remained unchanged during the hypotension while the total peripheral resistance decreased. Species differences may explain this discrepancy in response to endothelin in the rat vs cat. It might also be possible that due to the transient nature of the positive inotropic response the increase in cardiac index was not detected by the thermodilution technique since this method does not allow repetitive measurements within a short (Jess than 60 sec) time frame. However, our study clearly indicates that vasodilation leading to decreased peripheral vascular resistance underlies the hypotensive response to ET-1.
Our study reports for the first time profound hypertensive and tachycardic response and 90°/o mortality due to cardiovascular collapse after intracerebroventricular application of a picomole dose of ET -1 in the conscious rat. The extremely high potency of i.c.v. administered ET-1 implies that this peptide may be a neuromodulator important for the centrat cardiovascular regulation. Surprisingly, in our study no clear dose-response relationship of the central effects of ET-1 was established. This might indicate an extremely steep dose-response relationship to ET-1, but alternatively an unspecific toxic effect unrelated to a specific receptor cannot be excluded. However, the presence of specific binding sites for endothelin in many brain regions including the hypothalamic and brain stem cardiovascular nuclei (7, 8, 9) supports the possibility that endothelin might be a neurotransmitter.
In summary the present data demoostrate that profound cardiac depressor and peripheral vasoconstrictor responses underlie the previously described changes in blood pressure by ET-1. Our results also show that ET -1 is a most potent central modulator of the cardiovascular system at doses weil below any known peptide, amine, amino acid or other known neurotransmitter or neuromodulator. Therefore we suggest that endothelin might be a neuropeptide in the centrat cardiovascular control.
